APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Laminated Tubes for Pharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Laminated Tubes for Pharmaceuticals Market Outlook and Growth Opportunities 2026

Report ID 174496560412 August 2026203 pages

Choose your research edition.

Industry ResearchLaminated Tubes for Pharmaceuticals Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Laminated Tubes for Pharmaceuticals Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Laminated Tubes for Pharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Laminated Tubes for Pharmaceuticals Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Laminated Tubes for Pharmaceuticals Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Laminated Tubes for Pharmaceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Laminated Tubes for Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Laminated Tubes for Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Laminated Tubes for Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Laminated Tubes for Pharmaceuticals market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Laminated Tubes for Pharmaceuticals market include Essel Propack, Albea, Hoffmann Neopac AG, ALLTUB Group, Amcor plc, CCL Industries, Montebello Packaging, Pirlo Tubes GmbH and Perfektüp Ambalaj, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Laminated Tubes for Pharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Laminated Tubes for Pharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Laminated Tubes for Pharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Laminated Tubes for Pharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Laminated Tubes for Pharmaceuticals Segment by Company

Essel Propack

Albea

Hoffmann Neopac AG

ALLTUB Group

Amcor plc

CCL Industries

Montebello Packaging

Pirlo Tubes GmbH

Perfektüp Ambalaj

Scandolara

TUBAPACK

San Ying Packaging (Jiangsu) Co., Ltd.

Hangzhou Ming Ri Flexible Packaging Co., Ltd.

BRK Industries

DNP Group

Gualapack Group

Amber Tube

Laminated Tubes for Pharmaceuticals Segment by Type

Plastic Barrier Laminate (PBL) Tubes

Aluminum Barrier Laminate (ABL) Tubes

Laminated Tubes for Pharmaceuticals Segment by Application

Skin

Eyes

Mouth

Other

Laminated Tubes for Pharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Laminated Tubes for Pharmaceuticals status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Laminated Tubes for Pharmaceuticals market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Laminated Tubes for Pharmaceuticals significant trends, drivers, influence factors in global and regions.

6. To analyze Laminated Tubes for Pharmaceuticals competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laminated Tubes for Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Laminated Tubes for Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laminated Tubes for Pharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Laminated Tubes for Pharmaceuticals market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Laminated Tubes for Pharmaceuticals industry.

Chapter 3: Detailed analysis of Laminated Tubes for Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Laminated Tubes for Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Laminated Tubes for Pharmaceuticals in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Laminated Tubes for Pharmaceuticals Industry Trends Table 2. Laminated Tubes for Pharmaceuticals Industry Drivers Table 3. Laminated Tubes for Pharmaceuticals Industry Opportunities and Challenges Table 4. Laminated Tubes for Pharmaceuticals Industry Restraints Table 5. Global Laminated Tubes for Pharmaceuticals Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Laminated Tubes for Pharmaceuticals Revenue Share by Company (2021-2026) Table 7. Global Laminated Tubes for Pharmaceuticals Sales Volume by Company (k units) & (2021-2026) Table 8. Global Laminated Tubes for Pharmaceuticals Sales Volume Share by Company (2021-2026) Table 9. Global Laminated Tubes for Pharmaceuticals Average Price (USD/unit) of Company (2021-2026) Table 10. Global Laminated Tubes for Pharmaceuticals Company Ranking, (2024-2026) & (USD Million) Table 11. Global Laminated Tubes for Pharmaceuticals Key Company Manufacturing Base & Headquarters Table 12. Global Laminated Tubes for Pharmaceuticals Company, Product Type & Application Table 13. Global Laminated Tubes for Pharmaceuticals Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Laminated Tubes for Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plastic Barrier Laminate (PBL) Tubes Table 18. Significant Companies of Aluminum Barrier Laminate (ABL) Tubes Table 19. Global Laminated Tubes for Pharmaceuticals Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Laminated Tubes for Pharmaceuticals Sales Volume by Type (2021-2026) & (k units) Table 21. Global Laminated Tubes for Pharmaceuticals Sales Volume by Type (2027-2032) & (k units) Table 22. Global Laminated Tubes for Pharmaceuticals Sales Volume Share by Type (2021-2026) Table 23. Global Laminated Tubes for Pharmaceuticals Sales Volume Share by Type (2027-2032) Table 24. Global Laminated Tubes for Pharmaceuticals Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Laminated Tubes for Pharmaceuticals Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Laminated Tubes for Pharmaceuticals Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Laminated Tubes for Pharmaceuticals Sales Value Share by Type (2021-2026) Table 28. Global Laminated Tubes for Pharmaceuticals Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Skin Table 30. Significant Companies of Eyes Table 31. Significant Companies of Mouth Table 32. Significant Companies of Other Table 33. Global Laminated Tubes for Pharmaceuticals Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Laminated Tubes for Pharmaceuticals Sales Volume by Application (2021-2026) & (k units) Table 35. Global Laminated Tubes for Pharmaceuticals Sales Volume by Application (2027-2032) & (k units) Table 36. Global Laminated Tubes for Pharmaceuticals Sales Volume Share by Application (2021-2026) Table 37. Global Laminated Tubes for Pharmaceuticals Sales Volume Share by Application (2027-2032) Table 38. Global Laminated Tubes for Pharmaceuticals Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Laminated Tubes for Pharmaceuticals Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Laminated Tubes for Pharmaceuticals Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Laminated Tubes for Pharmaceuticals Sales Value Share by Application (2021-2026) Table 42. Global Laminated Tubes for Pharmaceuticals Sales Value Share by Application (2027-2032) Table 43. Global Laminated Tubes for Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Laminated Tubes for Pharmaceuticals Sales by Region (2021-2026) & (k units) Table 45. Global Laminated Tubes for Pharmaceuticals Sales Market Share by Region (2021-2026) Table 46. Global Laminated Tubes for Pharmaceuticals Sales by Region (2027-2032) & (k units) Table 47. Global Laminated Tubes for Pharmaceuticals Sales Market Share by Region (2027-2032) Table 48. Global Laminated Tubes for Pharmaceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Laminated Tubes for Pharmaceuticals Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Laminated Tubes for Pharmaceuticals Sales Value Share by Region (2021-2026) Table 51. Global Laminated Tubes for Pharmaceuticals Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Laminated Tubes for Pharmaceuticals Sales Value Share by Region (2027-2032) Table 53. Global Laminated Tubes for Pharmaceuticals Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Laminated Tubes for Pharmaceuticals Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Laminated Tubes for Pharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Laminated Tubes for Pharmaceuticals Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Laminated Tubes for Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 58. Global Laminated Tubes for Pharmaceuticals Sales Market Share by Country (2021-2026) Table 59. Global Laminated Tubes for Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 60. Global Laminated Tubes for Pharmaceuticals Sales Market Share by Country (2027-2032) Table 61. Global Laminated Tubes for Pharmaceuticals Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Laminated Tubes for Pharmaceuticals Sales Value Market Share by Country (2021-2026) Table 63. Global Laminated Tubes for Pharmaceuticals Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Laminated Tubes for Pharmaceuticals Sales Value Market Share by Country (2027-2032) Table 65. Essel Propack Company Information Table 66. Essel Propack Business Overview Table 67. Essel Propack Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Essel Propack Laminated Tubes for Pharmaceuticals Product Portfolio Table 69. Essel Propack Recent Development Table 70. Albea Company Information Table 71. Albea Business Overview Table 72. Albea Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Albea Laminated Tubes for Pharmaceuticals Product Portfolio Table 74. Albea Recent Development Table 75. Hoffmann Neopac AG Company Information Table 76. Hoffmann Neopac AG Business Overview Table 77. Hoffmann Neopac AG Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Hoffmann Neopac AG Laminated Tubes for Pharmaceuticals Product Portfolio Table 79. Hoffmann Neopac AG Recent Development Table 80. ALLTUB Group Company Information Table 81. ALLTUB Group Business Overview Table 82. ALLTUB Group Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. ALLTUB Group Laminated Tubes for Pharmaceuticals Product Portfolio Table 84. ALLTUB Group Recent Development Table 85. Amcor plc Company Information Table 86. Amcor plc Business Overview Table 87. Amcor plc Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Amcor plc Laminated Tubes for Pharmaceuticals Product Portfolio Table 89. Amcor plc Recent Development Table 90. CCL Industries Company Information Table 91. CCL Industries Business Overview Table 92. CCL Industries Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. CCL Industries Laminated Tubes for Pharmaceuticals Product Portfolio Table 94. CCL Industries Recent Development Table 95. Montebello Packaging Company Information Table 96. Montebello Packaging Business Overview Table 97. Montebello Packaging Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Montebello Packaging Laminated Tubes for Pharmaceuticals Product Portfolio Table 99. Montebello Packaging Recent Development Table 100. Pirlo Tubes GmbH Company Information Table 101. Pirlo Tubes GmbH Business Overview Table 102. Pirlo Tubes GmbH Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Pirlo Tubes GmbH Laminated Tubes for Pharmaceuticals Product Portfolio Table 104. Pirlo Tubes GmbH Recent Development Table 105. Perfektüp Ambalaj Company Information Table 106. Perfektüp Ambalaj Business Overview Table 107. Perfektüp Ambalaj Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Perfektüp Ambalaj Laminated Tubes for Pharmaceuticals Product Portfolio Table 109. Perfektüp Ambalaj Recent Development Table 110. Scandolara Company Information Table 111. Scandolara Business Overview Table 112. Scandolara Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Scandolara Laminated Tubes for Pharmaceuticals Product Portfolio Table 114. Scandolara Recent Development Table 115. TUBAPACK Company Information Table 116. TUBAPACK Business Overview Table 117. TUBAPACK Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. TUBAPACK Laminated Tubes for Pharmaceuticals Product Portfolio Table 119. TUBAPACK Recent Development Table 120. San Ying Packaging (Jiangsu) Co., Ltd. Company Information Table 121. San Ying Packaging (Jiangsu) Co., Ltd. Business Overview Table 122. San Ying Packaging (Jiangsu) Co., Ltd. Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. San Ying Packaging (Jiangsu) Co., Ltd. Laminated Tubes for Pharmaceuticals Product Portfolio Table 124. San Ying Packaging (Jiangsu) Co., Ltd. Recent Development Table 125. Hangzhou Ming Ri Flexible Packaging Co., Ltd. Company Information Table 126. Hangzhou Ming Ri Flexible Packaging Co., Ltd. Business Overview Table 127. Hangzhou Ming Ri Flexible Packaging Co., Ltd. Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Hangzhou Ming Ri Flexible Packaging Co., Ltd. Laminated Tubes for Pharmaceuticals Product Portfolio Table 129. Hangzhou Ming Ri Flexible Packaging Co., Ltd. Recent Development Table 130. BRK Industries Company Information Table 131. BRK Industries Business Overview Table 132. BRK Industries Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. BRK Industries Laminated Tubes for Pharmaceuticals Product Portfolio Table 134. BRK Industries Recent Development Table 135. DNP Group Company Information Table 136. DNP Group Business Overview Table 137. DNP Group Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. DNP Group Laminated Tubes for Pharmaceuticals Product Portfolio Table 139. DNP Group Recent Development Table 140. Gualapack Group Company Information Table 141. Gualapack Group Business Overview Table 142. Gualapack Group Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Gualapack Group Laminated Tubes for Pharmaceuticals Product Portfolio Table 144. Gualapack Group Recent Development Table 145. Amber Tube Company Information Table 146. Amber Tube Business Overview Table 147. Amber Tube Laminated Tubes for Pharmaceuticals Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Amber Tube Laminated Tubes for Pharmaceuticals Product Portfolio Table 149. Amber Tube Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Laminated Tubes for Pharmaceuticals Distributors List Table 153. Laminated Tubes for Pharmaceuticals Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Laminated Tubes for Pharmaceuticals Product Image Figure 2. Global Laminated Tubes for Pharmaceuticals Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Laminated Tubes for Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 4. Global Laminated Tubes for Pharmaceuticals Sales (2021-2032) & (k units) Figure 5. Global Laminated Tubes for Pharmaceuticals Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Laminated Tubes for Pharmaceuticals Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plastic Barrier Laminate (PBL) Tubes Image Figure 10. Aluminum Barrier Laminate (ABL) Tubes Image Figure 11. Global Laminated Tubes for Pharmaceuticals Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Laminated Tubes for Pharmaceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Laminated Tubes for Pharmaceuticals Sales Volume Share by Type (2021-2032) Figure 14. Global Laminated Tubes for Pharmaceuticals Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Laminated Tubes for Pharmaceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Laminated Tubes for Pharmaceuticals Sales Value Share by Type (2021-2032) Figure 17. Skin Image Figure 18. Eyes Image Figure 19. Mouth Image Figure 20. Other Image Figure 21. Global Laminated Tubes for Pharmaceuticals Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Laminated Tubes for Pharmaceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Laminated Tubes for Pharmaceuticals Sales Volume Share by Application (2021-2032) Figure 24. Global Laminated Tubes for Pharmaceuticals Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Laminated Tubes for Pharmaceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Laminated Tubes for Pharmaceuticals Sales Value Share by Application (2021-2032) Figure 27. Global Laminated Tubes for Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Laminated Tubes for Pharmaceuticals Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Laminated Tubes for Pharmaceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Laminated Tubes for Pharmaceuticals Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Laminated Tubes for Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 32. North America Laminated Tubes for Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Laminated Tubes for Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Laminated Tubes for Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Laminated Tubes for Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Laminated Tubes for Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Laminated Tubes for Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 38. South America Laminated Tubes for Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Laminated Tubes for Pharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Laminated Tubes for Pharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Laminated Tubes for Pharmaceuticals Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Laminated Tubes for Pharmaceuticals Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Plastic Barrier Laminate (PBL) Tubes
  • Aluminum Barrier Laminate (ABL) Tubes
Applications
  • Skin
  • Eyes
  • Mouth
  • Other
Companies covered
  • Essel Propack
  • Albea
  • Hoffmann Neopac AG
  • ALLTUB Group
  • Amcor plc
  • CCL Industries
  • Montebello Packaging
  • Pirlo Tubes GmbH
  • Perfektüp Ambalaj
  • Scandolara
  • TUBAPACK
  • San Ying Packaging (Jiangsu) Co., Ltd.
  • Hangzhou Ming Ri Flexible Packaging Co., Ltd.
  • BRK Industries
  • DNP Group
  • Gualapack Group
  • Amber Tube

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Laminated Tubes for Pharmaceuticals Sales Value (2021-2032)
  4. 1.2.2 Global Laminated Tubes for Pharmaceuticals Sales Volume (2021-2032)
  5. 1.2.3 Global Laminated Tubes for Pharmaceuticals Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Laminated Tubes for Pharmaceuticals Market Dynamics
  1. 2.1 Laminated Tubes for Pharmaceuticals Industry Trends
  2. 2.2 Laminated Tubes for Pharmaceuticals Industry Drivers
  3. 2.3 Laminated Tubes for Pharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Laminated Tubes for Pharmaceuticals Industry Restraints
3 Laminated Tubes for Pharmaceuticals Market by Company
  1. 3.1 Global Laminated Tubes for Pharmaceuticals Company Revenue Ranking in 2025
  2. 3.2 Global Laminated Tubes for Pharmaceuticals Revenue by Company (2021-2026)
  3. 3.3 Global Laminated Tubes for Pharmaceuticals Sales Volume by Company (2021-2026)
  4. 3.4 Global Laminated Tubes for Pharmaceuticals Average Price by Company (2021-2026)
  5. 3.5 Global Laminated Tubes for Pharmaceuticals Company Ranking (2024-2026)
  6. 3.6 Global Laminated Tubes for Pharmaceuticals Company Manufacturing Base and Headquarters
  7. 3.7 Global Laminated Tubes for Pharmaceuticals Company Product Type and Application
  8. 3.8 Global Laminated Tubes for Pharmaceuticals Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Laminated Tubes for Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Laminated Tubes for Pharmaceuticals Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Laminated Tubes for Pharmaceuticals Market by Type
  1. 4.1 Laminated Tubes for Pharmaceuticals Type Introduction
  2. 4.1.1 Plastic Barrier Laminate (PBL) Tubes
  3. 4.1.2 Aluminum Barrier Laminate (ABL) Tubes
  4. 4.2 Global Laminated Tubes for Pharmaceuticals Sales Volume by Type
  5. 4.2.1 Global Laminated Tubes for Pharmaceuticals Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Laminated Tubes for Pharmaceuticals Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Laminated Tubes for Pharmaceuticals Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Laminated Tubes for Pharmaceuticals Sales Value by Type
  9. 4.3.1 Global Laminated Tubes for Pharmaceuticals Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Laminated Tubes for Pharmaceuticals Sales Value by Type (2021-2032)
  11. 4.3.3 Global Laminated Tubes for Pharmaceuticals Sales Value Share by Type (2021-2032)
5 Laminated Tubes for Pharmaceuticals Market by Application
  1. 5.1 Laminated Tubes for Pharmaceuticals Application Introduction
  2. 5.1.1 Skin
  3. 5.1.2 Eyes
  4. 5.1.3 Mouth
  5. 5.1.4 Other
  6. 5.2 Global Laminated Tubes for Pharmaceuticals Sales Volume by Application
  7. 5.2.1 Global Laminated Tubes for Pharmaceuticals Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Laminated Tubes for Pharmaceuticals Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Laminated Tubes for Pharmaceuticals Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Laminated Tubes for Pharmaceuticals Sales Value by Application
  11. 5.3.1 Global Laminated Tubes for Pharmaceuticals Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Laminated Tubes for Pharmaceuticals Sales Value by Application (2021-2032)
  13. 5.3.3 Global Laminated Tubes for Pharmaceuticals Sales Value Share by Application (2021-2032)
6 Laminated Tubes for Pharmaceuticals Regional Sales and Value Analysis
  1. 6.1 Global Laminated Tubes for Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Laminated Tubes for Pharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Laminated Tubes for Pharmaceuticals Sales by Region: 2021-2026
  4. 6.2.2 Global Laminated Tubes for Pharmaceuticals Sales by Region (2027-2032)
  5. 6.3 Global Laminated Tubes for Pharmaceuticals Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Laminated Tubes for Pharmaceuticals Sales Value by Region (2021-2032)
  7. 6.4.1 Global Laminated Tubes for Pharmaceuticals Sales Value by Region: 2021-2026
  8. 6.4.2 Global Laminated Tubes for Pharmaceuticals Sales Value by Region (2027-2032)
  9. 6.5 Global Laminated Tubes for Pharmaceuticals Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Laminated Tubes for Pharmaceuticals Sales Value (2021-2032)
  12. 6.6.2 North America Laminated Tubes for Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Laminated Tubes for Pharmaceuticals Sales Value (2021-2032)
  15. 6.7.2 Europe Laminated Tubes for Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Laminated Tubes for Pharmaceuticals Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Laminated Tubes for Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Laminated Tubes for Pharmaceuticals Sales Value (2021-2032)
  21. 6.9.2 South America Laminated Tubes for Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Laminated Tubes for Pharmaceuticals Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Laminated Tubes for Pharmaceuticals Sales Value Share by Country, 2025 VS 2032
7 Laminated Tubes for Pharmaceuticals Country-level Sales and Value Analysis
  1. 7.1 Global Laminated Tubes for Pharmaceuticals Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Laminated Tubes for Pharmaceuticals Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Laminated Tubes for Pharmaceuticals Sales by Country (2021-2032)
  4. 7.3.1 Global Laminated Tubes for Pharmaceuticals Sales by Country (2021-2026)
  5. 7.3.2 Global Laminated Tubes for Pharmaceuticals Sales by Country (2027-2032)
  6. 7.4 Global Laminated Tubes for Pharmaceuticals Sales Value by Country (2021-2032)
  7. 7.4.1 Global Laminated Tubes for Pharmaceuticals Sales Value by Country (2021-2026)
  8. 7.4.2 Global Laminated Tubes for Pharmaceuticals Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Laminated Tubes for Pharmaceuticals Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Laminated Tubes for Pharmaceuticals Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Laminated Tubes for Pharmaceuticals Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Essel Propack
  2. 8.1.1 Essel Propack Company Information
  3. 8.1.2 Essel Propack Business Overview
  4. 8.1.3 Essel Propack Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Essel Propack Laminated Tubes for Pharmaceuticals Product Portfolio
  6. 8.1.5 Essel Propack Recent Developments
  7. 8.2 Albea
  8. 8.2.1 Albea Company Information
  9. 8.2.2 Albea Business Overview
  10. 8.2.3 Albea Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Albea Laminated Tubes for Pharmaceuticals Product Portfolio
  12. 8.2.5 Albea Recent Developments
  13. 8.3 Hoffmann Neopac AG
  14. 8.3.1 Hoffmann Neopac AG Company Information
  15. 8.3.2 Hoffmann Neopac AG Business Overview
  16. 8.3.3 Hoffmann Neopac AG Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hoffmann Neopac AG Laminated Tubes for Pharmaceuticals Product Portfolio
  18. 8.3.5 Hoffmann Neopac AG Recent Developments
  19. 8.4 ALLTUB Group
  20. 8.4.1 ALLTUB Group Company Information
  21. 8.4.2 ALLTUB Group Business Overview
  22. 8.4.3 ALLTUB Group Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ALLTUB Group Laminated Tubes for Pharmaceuticals Product Portfolio
  24. 8.4.5 ALLTUB Group Recent Developments
  25. 8.5 Amcor plc
  26. 8.5.1 Amcor plc Company Information
  27. 8.5.2 Amcor plc Business Overview
  28. 8.5.3 Amcor plc Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Amcor plc Laminated Tubes for Pharmaceuticals Product Portfolio
  30. 8.5.5 Amcor plc Recent Developments
  31. 8.6 CCL Industries
  32. 8.6.1 CCL Industries Company Information
  33. 8.6.2 CCL Industries Business Overview
  34. 8.6.3 CCL Industries Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CCL Industries Laminated Tubes for Pharmaceuticals Product Portfolio
  36. 8.6.5 CCL Industries Recent Developments
  37. 8.7 Montebello Packaging
  38. 8.7.1 Montebello Packaging Company Information
  39. 8.7.2 Montebello Packaging Business Overview
  40. 8.7.3 Montebello Packaging Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Montebello Packaging Laminated Tubes for Pharmaceuticals Product Portfolio
  42. 8.7.5 Montebello Packaging Recent Developments
  43. 8.8 Pirlo Tubes GmbH
  44. 8.8.1 Pirlo Tubes GmbH Company Information
  45. 8.8.2 Pirlo Tubes GmbH Business Overview
  46. 8.8.3 Pirlo Tubes GmbH Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pirlo Tubes GmbH Laminated Tubes for Pharmaceuticals Product Portfolio
  48. 8.8.5 Pirlo Tubes GmbH Recent Developments
  49. 8.9 Perfektüp Ambalaj
  50. 8.9.1 Perfektüp Ambalaj Company Information
  51. 8.9.2 Perfektüp Ambalaj Business Overview
  52. 8.9.3 Perfektüp Ambalaj Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Perfektüp Ambalaj Laminated Tubes for Pharmaceuticals Product Portfolio
  54. 8.9.5 Perfektüp Ambalaj Recent Developments
  55. 8.10 Scandolara
  56. 8.10.1 Scandolara Company Information
  57. 8.10.2 Scandolara Business Overview
  58. 8.10.3 Scandolara Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Scandolara Laminated Tubes for Pharmaceuticals Product Portfolio
  60. 8.10.5 Scandolara Recent Developments
  61. 8.11 TUBAPACK
  62. 8.11.1 TUBAPACK Company Information
  63. 8.11.2 TUBAPACK Business Overview
  64. 8.11.3 TUBAPACK Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 TUBAPACK Laminated Tubes for Pharmaceuticals Product Portfolio
  66. 8.11.5 TUBAPACK Recent Developments
  67. 8.12 San Ying Packaging (Jiangsu) Co., Ltd.
  68. 8.12.1 San Ying Packaging (Jiangsu) Co., Ltd. Company Information
  69. 8.12.2 San Ying Packaging (Jiangsu) Co., Ltd. Business Overview
  70. 8.12.3 San Ying Packaging (Jiangsu) Co., Ltd. Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 San Ying Packaging (Jiangsu) Co., Ltd. Laminated Tubes for Pharmaceuticals Product Portfolio
  72. 8.12.5 San Ying Packaging (Jiangsu) Co., Ltd. Recent Developments
  73. 8.13 Hangzhou Ming Ri Flexible Packaging Co., Ltd.
  74. 8.13.1 Hangzhou Ming Ri Flexible Packaging Co., Ltd. Company Information
  75. 8.13.2 Hangzhou Ming Ri Flexible Packaging Co., Ltd. Business Overview
  76. 8.13.3 Hangzhou Ming Ri Flexible Packaging Co., Ltd. Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hangzhou Ming Ri Flexible Packaging Co., Ltd. Laminated Tubes for Pharmaceuticals Product Portfolio
  78. 8.13.5 Hangzhou Ming Ri Flexible Packaging Co., Ltd. Recent Developments
  79. 8.14 BRK Industries
  80. 8.14.1 BRK Industries Company Information
  81. 8.14.2 BRK Industries Business Overview
  82. 8.14.3 BRK Industries Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 BRK Industries Laminated Tubes for Pharmaceuticals Product Portfolio
  84. 8.14.5 BRK Industries Recent Developments
  85. 8.15 DNP Group
  86. 8.15.1 DNP Group Company Information
  87. 8.15.2 DNP Group Business Overview
  88. 8.15.3 DNP Group Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 DNP Group Laminated Tubes for Pharmaceuticals Product Portfolio
  90. 8.15.5 DNP Group Recent Developments
  91. 8.16 Gualapack Group
  92. 8.16.1 Gualapack Group Company Information
  93. 8.16.2 Gualapack Group Business Overview
  94. 8.16.3 Gualapack Group Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Gualapack Group Laminated Tubes for Pharmaceuticals Product Portfolio
  96. 8.16.5 Gualapack Group Recent Developments
  97. 8.17 Amber Tube
  98. 8.17.1 Amber Tube Company Information
  99. 8.17.2 Amber Tube Business Overview
  100. 8.17.3 Amber Tube Laminated Tubes for Pharmaceuticals Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Amber Tube Laminated Tubes for Pharmaceuticals Product Portfolio
  102. 8.17.5 Amber Tube Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Laminated Tubes for Pharmaceuticals Value Chain Analysis
  2. 9.1.1 Laminated Tubes for Pharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Laminated Tubes for Pharmaceuticals Sales Mode & Process
  6. 9.2 Laminated Tubes for Pharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Laminated Tubes for Pharmaceuticals Distributors
  9. 9.2.3 Laminated Tubes for Pharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst